← SynDRA
FESOTERODINE
SynDRA canonical compound SYN0023610 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | CHRM1 | CHRM2 | CHRM3 | CHRM4 | CHRM5 |
|---|
| Mechanism of action | acetylcholine receptor antagonist |
|---|
| Indication | urinary incontinence |
|---|
| Disease area | urology |
|---|
All known targets
- CHRM1
- CHRM2
- CHRM3
- CHRM4
- CHRM5
Mechanisms of action (all sources)
- CHRM3 ANTAGONIST
- Muscarinic acetylcholine receptor M3 antagonist
- CHRM2 ANTAGONIST
- Muscarinic acetylcholine receptor M2 antagonist
- acetylcholine receptor antagonist
- CHRM1 MODULATOR
Drug classes
- Cholinergic Agents
- Cholinergic Antagonists
- Muscarinic Antagonists
- Neurotransmitter Agents
- Urological Agents
ATC classes
Cross-references
Synonyms
- toviaz
- fesoterodine fumarate
- Fesoterodina
- Fesoterodine fumarate
- Toviaz (TN)
- fesoterodinum
- RefChem:57404
- DTXCID20105344
- G04BD11
- (R) Fesoterodine
- Fesoterodine (INN)
- FESOTERODINE [INN]
- Fesoterodine maleate
- Fesoterodine [INN:BAN]
- MFCD07772311
- UNII-621G617227
- FESO
- starbld0000599
- FESOTERODINE [MI]
- FESOTERODINE [VANDF]
- FESOTERODINE [MART.]
- FESOTERODINE [WHO-DD]
- SCHEMBL121127
- GTPL7473
- orb1298106
- SCHEMBL29366015
- CHEBI:135920
- DCCSDBARQIPTGU-HSZRJFAPSA-N
- CS-M2392
- BDBM50248002
- EBC-26996
- AKOS015841710
- NCGC00346540-01
- NCGC00346540-02
- NCGC00346540-03
- AC-32493
- DA-73341
- HY-70053
Look up FESOTERODINE in the interactive SynDRA portal →